DarioHealth
DRIO
20 hedge funds and large institutions have $4.57M invested in DarioHealth in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.01% more ownership
Funds ownership: 0.05% → 0.06% (+0.01%)
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
14% less capital invested
Capital invested by funds: $5.31M → $4.57M (-$741K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$604K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$540K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$200K |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
+$19.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$10.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$28K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$19.2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14K |
| 4 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$11K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.6K |
DRIO Hedge Fund Activity: Q2 2019 in Review
20 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2019, worth a combined $4.57M — down 14% from $5.31M a quarter earlier.
Fund positioning in DRIO was balanced in Q2 2019: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $604K. The largest seller was BlackRock, exiting entirely with an estimated $28K sold.
- 20 institutional investors held DarioHealth (DRIO) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $4.57M of DarioHealth stock for Q2 2019, down 14% quarter-over-quarter.
- 3 funds opened new DarioHealth positions in Q2 2019 and 3 closed out, a net change of 0 holders.
- The largest DarioHealth buyer in Q2 2019 was Nantahala Capital Management, an estimated $604K added.
- The largest DarioHealth seller in Q2 2019 was BlackRock, an estimated $28K sold.
Based on aggregated 13F filings for Q2 2019.